Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration

Neurology

Volumn 38, Issue 8, 1988, Pages 1237-1244

  Doty, Richard L ^a   Deems, Daniel A ^a   Stellar, Stanley ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SAINT BARNABAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OLFACTORY SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; FEMALE; HUMAN; MALE; MIDDLE AGE; PARKINSON DISEASE; SMELL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023765129     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.38.8.1237     Document Type: Article

References (58)

1. Burdach KJ, Doty RL. The effecta of mouth movements, swallowing and apitting on retronasal odor perception. Physiol Behav 1987;41:353–356.
2. Doty RL, Kimmelman CP. Smell and taste and their diaordere. In: Asbury AK, McKhann GM, McDonald WI, eds. Diseases of the nervous system. Philadelphia: WB Saunders, 1986:465–478.
3. Mozell MM, Smith BP, Smith PE, et al. Nasal chemoreception in flavor identification. Arch Otolaryngol 1969;90:131–137.
4. Roberta R. Alzheimer’s disease may begin in the now and may be caused by aluminosilicates. Neurobiol Aging 1986;7:561–567.
5. Jones BP, Moskowitz HR, Butters N. Olfactory quality diecrimination in alcoholic Korsakoff patients. Neuropsychologia 1975;13:173–179.
6. Jones BP, Butters N, Moskowitz HR, et al. Olfactory and gustatory capacities of alcoholic Koreakoff patients. Neuropsychologia 1978;16:323–336.
7. Mair RG, Doty RL, Kelly KM, et al. Multimodal sensory diacrimination deficits in Korsakoff’s psychosis. Neuropsychologia 1986;24:831–839.
8. Anasari KA, Johnson A. Olfactory function in patients with Parkinson’s disease. J Chronic Dis 1975;28:493–497.
9. Quinn NP, Rossor MN, Maraden CD. Olfactory threshold in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1987;50:88–89.
10. Ward CD, Hess WA, Calne DB. Olfactory impairment in Parkinson’s disease. Neurology 1983;33:943–946.
11. Doty RL, Reyes P, Gregor T. Presence of both odor identification and detection deficits in Alzheimer’s disease. Brain Res Bull 1987;18:597–600.
12. Knupfer L, Spiegel R. Differences in olfactory test performance between normal aged, Alzheimer and vascular type dementia individuals. Int J Geriatr Psychiatry 1986;1:3–14.
13. Warner MD, Peabody CA, Flattery JJ, et al. Olfactory deficits and Alzheimer’s disease. Biol Psychiatry 1986;21:116–118.
14. Monath TP, Croop CB, Harrison AK. Mode of entry of a neuro-tropic arbovinu, into the central nervous system: reinvestigation of an old controversy. Lab Invest 1983;48:399–410.
15. Shipley MT. Transport of molecules from nose to brain. transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutin-horseradish peroxidase applied to the nasal epithelium. Brain Res Bull 1985;15:129–142.
16. Tomlinson AH, Esiri MM. Herpes simplex encephalitis: immuno-histological demonstration of spread of virus via olfactory pathways in mice. J Neurol Sci 1983;60:473–464.
17. Esiri MM, Wilcock GK. The olfactory bulb in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1984;47:56–60.
18. Hooper MW, Vogel FS. The limbic system in Alzheimer’s disease. Am J Pathol 1976;85:1–13.
19. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci USA 1985;82:4531–4534.
20. Reyes PF, Golden GT, Fagel PL, et al. The prepiriform cortex in dementia of the Alzheimer type. Arch Neurol 1987;50:113–115.
21. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427–442.
22. Doty RL, Shaman P, Applebaum SL, et al. Smell identification ability: changes with age. Science 1984;226:1441–1443.
23. Doty RL. The Smell Identification Test™ Administration Manual. Philadelphia: Sensonics, Inc., 1983.
24. Deems DA, Doty RL. The nature of age-related olfactory detection threshold changes in man. Trans Pa Acad Opthalmol Otolaryngol 1987;39:646–650.
25. Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized micro-encapsulated test of olfactory function. Physiol Behav 1984;32:489–502.
26. Doty RL, Newhouse MG, Azzalina JD. Internal consistency and short-term test-retest reliability of the University of Pennsylvania Smell Identification Test. Chem Senses 1985;10:297–300.
27. Polak EG. Multiple profile-multiple receptor site model for vertebrate olfaction. J Theor Biol 1973;40:469–484.
28. Weiffenbach JM, McCarthy VP. Olfactory deficita in cystic fibro-sis: distribution and severity. Chem Senses 1984;9:193–199.
29. Doty RL, Gregor T, Settle RG. Influences of intertrial interval and sniff bottle volume on the phenyl ethyl alcohol olfactory detection threshold. Chem Senses 1986;11:259–264.
30. Doty RL, Brugger WE, Jurs PC, et al. Intrand trigeminal stimulation from odorous volatiles: psychometric responses from anosmic and normal humans. Physiol Behav 1978;20:175–185.
31. Moncrieff RW. Olfactory adaptation and odor intensity. Am J Psychol 1957;70:1–20.
32. Yoshida M. Correlation analysis of detection threshold data for “standard test” odors. Bull Facul Sci Eng Chuo Univ 1984;27:343–353.
33. Vollmecke T, Doty RL. Development of the Picture Identification Test (PIT): a research companion to the University of Pennsylvania Smell Identification Test. Chem Senses 1985;10:413–414.
34. Doty RL, Riklan M, Deems DA, Reynolds C, Stellar S. The olfactory and cognitive deficits of Parkinson’s disease are independent. (Submitted).
35. Wechaler D. WAIS-R Manual. New York The Psychological Corporation, 1981.
36. Randt CT, Brown ER, Osborne D. A memory test for longitudinal measurement of mild to moderate deficits. Clin Neuropsychol 1980;2:184–194.
37. Riklin M, Reynolds C, Stellar S. Correlates of memory in Parkinson’s disease. J Nerv Ment Dis (in press).
38. Nie NH, Hull CH, Jenkins JG, Steinbrenner K, Bent DH. Statietical package for the social sciences. New York: McGraw-Hill. 1975.
39. Growdon JH, Corkin S. Cognitive impairments in Parkinson’s disease. In: Yahr MD, Bergmann KJ, eds. Advances in neurology. New York: Raven Press, 1986:383–392.
40. Korten JJ, Meulstee J. Olfactory disturbances in parkinsonism. Clin Neurol Neurosurg 1980;82:113–118.
41. Ophir D, Gross-Isseroff R, Lancet D, Mmhak G. Changes in olfactory acuity induced by total inferior turbinectomy. Arch Otolaryngol 1986;112:195–197.
42. Petrinovich L, Hardyck C. Behavioral changes in Parkinson patients following surgery: a factor analytic study. J Chronic Dis 1964;17:225–233.
43. Van Manen J. Factor-analytic studies of the symptoms of Parkinson’s disease. Confin Neurol 1967;29:127–132.
44. Reynolds NC, Montgomery GK. Factor analysis of Parkinson’s impairment. Arch Neurol 1987;44:1013–1016.
45. Kuypers HGJM. Descending pathways of the spinal cord. J Neurosurg 1966;24(suppl):200–202.
46. Chui HC, Mortimer JA, Slager U, et al. Pathologic correlates of dementia in Parkinson’s dim. Arch Neurol 1986;43:991–995.
47. Leverenz J, Sumi SM. Parkinson’s disease in patients with Alzheimer’s disease. Arch Neurol 1986;43:662–664.
48. Doty RL, Snow JB Jr. Olfaction. In: Goldman JL, ed. The principles and practice of rhinology. New York: John Wiley & Sons, 1987:761–785.
49. Cash R, Dennis T, L’Heureux R, Raiaman R, Javoy-Agid F, Scatton B. Parkinson’s disease and dementia: norepinephrine and dopamine in locue ceruleus. Neurology 1987;37:42–46.
50. Doty RL, Ferguson-Segall M, Lucki I, Kreider M. Effects of intrabulbar injections of 6-hydroxydopamine on ethyl acetate odor detection in castrate and non-castrate male rats. Brain Res 1988;444:95–103.
51. Doty RL, Ferguson-Segall M. Odor detection performance of rats following d-amphetamine treatment: a signal detection analysis. Psychopharmacology 1987;93:87–93.
52. Proctor F, Riklan M, Cooper IS, Teuber HL. Judgment of visual and postural vertical by parkinsonian patients. Neurology 1964;14:287–293.
53. Danta G, Hilton RC. Judgment of the visual vertical and horizontal in patients with parkinsonism. Neurology 1975;25:43–47.
54. Bhaskar PA, Vanchilingam S, Bhaskar EA, Devaprabhu A, Ganesan RA. Effect of L-dopa on visual evoked potential in patienta with Parkinson’s disease. Neurology 1986;36:1119–1121.
55. Economou SG, Stefanis CN. Changes of electmulogram (EOG) in Parkinson’s disease. Acta Neurol Scand 1978;58:41–52.
56. Bodis-Wollner I, Yahr M. Measurements of visual evoked potentials in Parkinson’s disease. Brain 1978;101:661–671.
57. Gawel MJ, Das P, Vincent S, Rose FC. Visual and auditory evoked potentials in Parkinson’s disease. Brain 1978;101:661–671.
58. Bulens C, Meerwaldt JD, van der Wildt GJ, Keemink CJ. Contrast sensitivity in Parkinson’s disease. Neurology 1986;36:1121–1125.